Advanced Filters
noise

Obesity Clinical Trials

A listing of Obesity medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,166 clinical trials
D Dharini M Bhammar, PhD

Inspiratory Muscle Training in Obese Breast Cancer Survivors

The investigators propose a randomized controlled trial to determine the effectiveness of inspiratory muscle training in improving exercise tolerance among stage 0-III obese breast cancer survivors.

18 years of age Female Phase N/A
A Andrea S. Lukes, MD

Phase II Study of Ovulation in Obese Women

The goal of this clinical trial is to compare the delay in ovulation between placebo to levonorgestrel plus meloxicam in obese women with normal menses. The main questions it aims to answer are: Ovulation will be delayed by ≥7 days following the first dose of levonorgestrel plus meloxicam compared to …

18 - 40 years of age Female Phase 2
J Jeffrey P Nadwodny, DO

Knee Injections for Obese Patients With Knee Arthritis

The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.

55 - 85 years of age All Phase 4
X Xuening Li

Evaluate LAE102 in Healthy and Overweight/Obese Subjects

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE102 injection in healthy and overweight/obese participants, and also evaluate the preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants.

18 - 65 years of age All Phase 1
Y Yingpeng Tian

Lactobacillus Plantarum and Hormonal Regulation in Obese Women

To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.

18 - 40 years of age Female Phase N/A
N Nicholas A Burd, PhD

Stable Isotopes- Adults With Obesity

In a crossover design, 8 participants will receive caloric drinks containing stable isotopes. In one arm of the study, participants will consume 6 hourly drinks containing two stable isotopes. Repeated blood, breath, urine, and muscle biopsies will be taken. In the second arm, participants will consume 1 drink containing 75g …

19 - 59 years of age All Phase N/A
A Amit Pai, PharmD

Vancomycin Dose Optimization in Obesity

The goal of this clinical trial is to learn how to optimize vancomycin dosing in obese adults based on weight and kidney function. It will also assess the safety of different vancomycin dosing strategies. The main questions it aims to answer are: Does dosing vancomycin based on kidney function provide …

18 - 50 years of age All Phase 1
J JINGJING JIANG, MD

Asiaticoside for Treating Overweight/Obesity

Centella asiatica is a traditional herbal medicine widely used in China and Southeast Asia for treating various conditions. Preclinical studies have shown that madecassic acid glycosides, including asiaticoside and madecassoside, can significantly reduce body weight gain, adipose tissue mass, and serum triglyceride levels in high-fat diet-induced obese mice. These compounds …

18 years of age All Phase N/A

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.

13 - 30 years of age All Phase N/A
B Braiden Valdarchi, BSc

A Behavioural Weight Loss Intervention Delivered in Cardiac Rehabilitation for Patients With Atrial Fibrillation and Obesity

One-in-four Canadians will be diagnosed with an abnormal heart rhythm called atrial fibrillation (AF) in their lifetime. This is expected to double by 2050, owing to an aging population and increased age- and health behaviour-associated AF risk factors (e.g., poor cardiorespiratory fitness, Type II diabetes, hypertension, and obesity). AF is …

18 years of age All Phase N/A

Simplify language using AI